| Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor (NCT05065021) | University Health Network, Toronto | 2023-02-23 |
| LEV102 Topical Gel in Acquired Blepharoptosis (NCT05715346) | Levation Pharma, Ltd. | 2023-02-23 |
| Phase Ib/IIa Trial With AC01 in Patients With HFrEF (NCT05642507) | AnaCardio AB | 2023-02-23 |
| A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza (NCT05648448) | University of Oxford | 2023-02-22 |
| A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma (NCT05800977) | Shanghai AbelZeta Ltd. | 2023-02-22 |
| Allogeneic Transplantation of Expanded Pancreatic Islet Cells (NCT05990530) | Shanghai Jiao Tong University School of Medicine | 2023-02-22 |
| Impact of Black Seed Oil on Hemodialysis Patients (NCT05822661) | Ain Shams University | 2023-02-22 |
| Sonodynamic Therapy With ExAblate System in Glioblastoma Patients (NCT04845919) | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 2023-02-22 |
| Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell Disease (NCT05565092) | Alexion Pharmaceuticals, Inc. | 2023-02-22 |
| Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive. (NCT05785390) | Novatek Pharmaceuticals | 2023-02-22 |
| Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer (NCT05800587) | Fox Chase Cancer Center | 2023-02-22 |
| Autologous Transplantation of Expanded Pancreatic Islet Cells (YD01-2022) in Patients (NCT05990517) | Shanghai Jiao Tong University School of Medicine | 2023-02-22 |
| SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF) (NCT05747430) | iRenix Medical, Inc. | 2023-02-22 |
| Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer (NCT05731726) | Zhejiang University | 2023-02-22 |
| A Study of JNJ-64281802 for the Prevention of Dengue Infection (NCT05201794) | Janssen Research & Development, LLC | 2023-02-22 |
| A Study of KC1036 in Patients with Advanced Thymic Tumors (NCT05683886) | Beijing Konruns Pharmaceutical Co., Ltd. | 2023-02-22 |
| Response to Immunotherapy in MMR-deficient Localized Colon Cancer (NCT05662527) | Camilla Qvortrup | 2023-02-22 |
| A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013) (NCT05810948) | argenx | 2023-02-21 |
| De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA (NCT05541016) | Mayo Clinic | 2023-02-21 |
| ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer. (NCT05632939) | AskGene Pharma, Inc. | 2023-02-21 |
| Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management (NCT05744674) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2023-02-21 |
| Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids (NCT05024734) | Roland Seiler-Blarer | 2023-02-21 |
| Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms (NCT05732961) | H. Lee Moffitt Cancer Center and Research Institute | 2023-02-21 |
| An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease (NCT05522387) | Inmune Bio, Inc. | 2023-02-21 |
| A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema (NCT05695248) | Astria Therapeutics, Inc. | 2023-02-21 |
| A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL (NCT05627856) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-02-21 |
| PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE) (NCT05419193) | Beijing Tiantan Hospital | 2023-02-21 |
| A Phase I/II Study of GLB-COV2-043 as a COVID-19 Vaccine Booster (NCT05602961) | GreenLight Biosciences, Inc. | 2023-02-21 |
| Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO) (NCT06091826) | NFL Biosciences SAS | 2023-02-21 |
| HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR) (NCT05632861) | Tasly Pharmaceutical Group Co., Ltd | 2023-02-21 |
| A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations (NCT05503797) | Fore Biotherapeutics | 2023-02-21 |
| Divided or Single Exposure (DOSE) Study (NCT05459402) | University of Maryland, Baltimore | 2023-02-21 |
| A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma (NCT05716087) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2023-02-21 |
| Study With Various Immunotherapy Treatments in Participants With Lung Cancer (NCT05676931) | Gilead Sciences | 2023-02-21 |
| The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study (NCT05574400) | University of Michigan | 2023-02-20 |
| NOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation (NCT05073822) | University College, London | 2023-02-20 |
| Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology (NCT05664178) | H. Lee Moffitt Cancer Center and Research Institute | 2023-02-20 |
| Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer (NCT05889390) | Semmelweis University | 2023-02-20 |
| COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study (NCT05518487) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-02-20 |
| Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004) (NCT05281003) | Fudan University | 2023-02-20 |
| A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014) (NCT05810961) | argenx | 2023-02-20 |
| A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia (NCT05736965) | Shanghai Tong Ren Hospital | 2023-02-20 |
| Intra-ovarian Injection of MSC-EVs in Idiopathic Premature Ovarian Failure (NCT06202547) | Royan Institute | 2023-02-20 |
| Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer (NCT05889728) | St Vincent's Hospital, Sydney | 2023-02-20 |
| Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis (NCT03749317) | IVIEW Therapeutics Inc. | 2023-02-20 |
| Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts (NCT05005182) | Mayo Clinic | 2023-02-20 |
| Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC (NCT06427005) | Meng Qiu | 2023-02-20 |
| Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) (NCT05814640) | First Affiliated Hospital of Chongqing Medical University | 2023-02-20 |
| Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors (NCT05700669) | Valerio Therapeutics | 2023-02-20 |
| A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old (NCT02616302) | Takeda | 2023-02-20 |
| Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy (NCT05832684) | Chigenovo Co., Ltd | 2023-02-20 |
| Triple Therapy Strategy for Managing Persistent Pain After Spinal Microdiscectomy (NCT07370233) | Benha University | 2023-02-20 |
| A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients (NCT05764590) | Alebund Pharmaceuticals | 2023-02-20 |
| Montmorency Cherry Supplementation, Sleep, and Inflammation (NCT05700643) | Michigan State University | 2023-02-18 |
| Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19 (NCT05639166) | Immune Biosolutions Inc | 2023-02-18 |
| Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell Carcinoma (NCT05760053) | Sun Yat-sen University | 2023-02-18 |
| Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fog Symptoms in Patients After COVID-19. (NCT06012552) | Military Institute od Medicine National Research Institute | 2023-02-17 |
| Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis (NCT05749822) | Xijing Hospital of Digestive Diseases | 2023-02-17 |
| Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT05498220) | UNC Lineberger Comprehensive Cancer Center | 2023-02-17 |
| Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer (NCT05617313) | Jeffrey Clarke | 2023-02-17 |
| Evaluation of the Efficacy of an Intra-articular Injection of Autologous Microfat Combined With Autologous Platelet-enriched Plasma in the Treatment of Radiocarpal Osteoarthritis: a Randomized Controlled Non-inferiority Trial Versus Total Wrist Denervation (Established Standard Treatment). (NCT05501743) | Assistance Publique Hopitaux De Marseille | 2023-02-17 |
| Inhaled NO in Surgical Patients With Recent COVID-19 Infection (NCT05721144) | Xijing Hospital | 2023-02-17 |
| Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors (NCT05247905) | Alliance for Clinical Trials in Oncology | 2023-02-16 |
| Effect of Short-Term Prednisone Therapy on C-Reactive Protein Change in Emergency Department Patients With Acute Heart Failure and Elevated Inflammatory Markers ( CORTAHF ) (NCT05668676) | Assistance Publique - Hôpitaux de Paris | 2023-02-16 |
| Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab (NCT05319639) | Fujian Cancer Hospital | 2023-02-16 |
| Platelet Rich Plasma Uterine Infusion (NCT06621342) | University of Kansas Medical Center | 2023-02-16 |
| CD8 Minibody Repeatability Study (NCT05744128) | ImaginAb, Inc. | 2023-02-16 |
| Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT05816499) | Shanghai Chest Hospital | 2023-02-16 |
| Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1 (NCT05614531) | Guangzhou Jiayin Biotech Ltd | 2023-02-16 |
| Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer (NCT05817214) | Zhongnan Hospital | 2023-02-16 |
| A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia (NCT05655819) | David J. Cangemi | 2023-02-16 |
| Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole (NCT05286437) | National Cancer Centre, Singapore | 2023-02-15 |
| Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment (NCT05427630) | University of California, San Diego | 2023-02-15 |
| A Clinical Trial in Subjects With Atopic Dermatitis (Part 1) (NCT05717920) | Aldeyra Therapeutics, Inc. | 2023-02-15 |
| Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) (NCT05518188) | Elpida Therapeutics SPC | 2023-02-15 |
| A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome (NCT05690386) | Ascendis Pharma Endocrinology Division A/S | 2023-02-15 |
| A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery (NCT05549505) | Arvinas Inc. | 2023-02-15 |
| DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29) (NCT06276283) | Dizal Pharmaceuticals | 2023-02-15 |
| Efficacy of Sodium Thiosulfate and Mannitol in Reducing Ototoxicity in Adult Patients Receiving Cisplatin Chemotherapy (NCT05129748) | Sunnybrook Health Sciences Centre | 2023-02-15 |
| Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002) (NCT05710224) | Butantan Institute | 2023-02-15 |
| Virtual Reality Intervention for Skill Acquisition Support in Autism Spectrum Disorder (ASD) (NCT05791071) | Floreo, Inc. | 2023-02-15 |
| Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation (NCT05523440) | University of Oklahoma | 2023-02-15 |
| Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM (NCT05914662) | Institute of Hematology & Blood Diseases Hospital, China | 2023-02-15 |
| Tracer-Guided Surgery for Recurrent Prostate Cancer (NCT05555017) | The Netherlands Cancer Institute | 2023-02-15 |
| A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients (NCT05139719) | Sunshine Lake Pharma Co., Ltd. | 2023-02-15 |
| Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal Cancer (NCT05721872) | Nazarbayev University | 2023-02-15 |
| Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH (NCT06297434) | J2H Biotech | 2023-02-15 |
| Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma (NCT05809869) | The University of Hong Kong | 2023-02-15 |
| Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer (NCT05815862) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-02-15 |
| Coconut Oil to Prevent Mouth Sores in Pediatric Patients Receiving High Dose Chemotherapy (NCT05441813) | Wake Forest University Health Sciences | 2023-02-15 |
| Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED) (NCT05683496) | ACELYRIN Inc. | 2023-02-14 |
| Ointment to Prevent Scar After Thyroidectomy (NCT05838833) | Innovo Therapeutics, Inc. | 2023-02-14 |
| (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer (NCT05607004) | Atossa Therapeutics, Inc. | 2023-02-14 |
| A Study of IBI311 in Subjects With Active Thyroid Eye Disease (NCT05795621) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-02-14 |
| Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer (NCT05751941) | H. Lee Moffitt Cancer Center and Research Institute | 2023-02-14 |
| Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria (NCT05718375) | Curacle Co., Ltd. | 2023-02-14 |
| Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS) (NCT05661188) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2023-02-14 |
| A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD (NCT05822908) | Vico Therapeutics B. V. | 2023-02-14 |
| Subdermal Implant-bioabsorbable Gestrinone Pellet for Endometriosis Pelvic Pain Treatment (NCT05570786) | Science Valley Research Institute | 2023-02-13 |
| Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma (NCT05504720) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2023-02-13 |